Market Exclusive Biotech News & Analysis

Adaptimmune Therapeutics Just Scored Big In Early Stage Data

Adaptimmune Therapeutics plc (NASDAQ:ADAP) is having an incredibly strong close to the end of the week in the biotechnology space. On Thursday, the company...
AbbVie Inc

Proteostasis and AbbVie Are Gaining Strength On Development Updates

Proteostasis Therapeutics, Inc. (NASDAQ:PTI) gained a considerable amount of strength during the session on Monday on the back of some news related to one...